Position: Executive Vice President and CFO, H. Lundbeck A/S
Joined the Board: 19 March 2018
Period of office ends: General Assembly 2022
Chair of the Audit Committee
Chair: Rosborg Møbler A/S
Board member and Chair of Audit Committee: Veloxis Pharmaceuticals A/S, Obsidian Therapeutics Inc
The Board of Directors is of the opinion that Anders Götzsche possesses the following special competences: International management and board experience, expertise in finance and accounting as well as M&A.